Results 161 to 170 of about 1,464,129 (347)

Comparison of an oncology clinical decision-support system’s recommendations with actual treatment decisions [PDF]

, 2021
Suthida Suwanvecho, Harit Suwanrusme, Tanawat Jirakulaporn, Surasit Issarachai, Nimit Taechakraichana, Palita Lungchukiet, Wimolrat Decha, Wisanu Boonpakdee, Nittaya Thanakarn, Pattanawadee Wongrattananon, Anita M. Preininger, Metasebya Solomon, Suwei Wang, Rezzan Hekmat, Irene Dankwa‐Mullan, Edward H. Shortliffe, Vimla L. Patel, Yull Arriaga, Gretchen Purcell Jackson, Narongsak Kiatikajornthada   +19 more
openalex   +1 more source

Tumor and germline testing with next generation sequencing in epithelial ovarian cancer: a prospective paired comparison using an 18‐gene panel

Molecular Oncology, EarlyView.
Genetic testing in epithelial ovarian cancer includes both germline and tumor‐testing. This approach often duplicates resources. The current prospective study assessed the feasibility of tumor‐first multigene testing by comparing tumor tissue with germline testing of peripheral blood using an 18‐gene NGS panel in 106 patients.
Elisabeth Spenard, Cristina Mitric, Melanie Care, Tracy L. Stockley, Raymond H. Kim, Jeanna McCuaig, Blaise Clarke, Laura Ranich, Clare Sheen, Sarah E. Ferguson, Liat Hogen, Taymaa May, Marcus Q. Bernardini   +12 more
wiley   +1 more source

Clinical Applications of Next-Generation Sequencing in Precision Oncology

, 2019
Chris Karlovich, P. Mickey Williams
openalex   +2 more sources

The neural crest‐associated gene ERRFI1 is involved in melanoma progression and resistance toward targeted therapy

Molecular Oncology, EarlyView.
ERRFI1, a neural crest (NC)‐associated gene, was upregulated in melanoma and negatively correlated with the expression of melanocytic differentiation markers and the susceptibility of melanoma cells toward BRAF inhibitors (BRAFi). Knocking down ERRFI1 significantly increased the sensitivity of melanoma cells to BRAFi.
Nina Wang, Qian Sun, Daniel Novak, Lei Zhu, Juliane Poelchen, Tamara Steinfass, Yiman Wang, Viktor Umansky, Jochen Utikal   +8 more
wiley   +1 more source

A Phase I/II Study of Continuous Intra-arterial Chemotherapy Using an Implantable Reservoir for the Treatment of Liver Metastases from Breast Cancer: A Japan Clinical Oncology Group (JCOG) Study 9113 [PDF]

, 1999
Tadashi Ikeda, I Adachi, S Takashima, Masami Ogita, Hideaki Aoyama, Muneaki Sano, Jiro Ando, Toshio Tabei, T. Tominaga, Koji Enomoto, Katsuya Kanda, Takashi Fukutomi, M Shimoyama, JCOG Breast Cancer Study Group   +13 more
openalex   +1 more source

Implementing oncology clinical trials in Nigeria: a model for capacity building [PDF]

, 2020
Atara Ntekim, Abiola Ibraheem, Adenike Adeniyi-Sofoluwe, Toyosi Adepoju, Mojisola Oluwasanu, Toyin Aniagwu, Olutosin Awolude, Williams Balogun, Olayinka Kotila, Prisca Olabisi Adejumo, Chinedum P. Babalola, Ganiyu Olatunbosun Arinola, Oladosu Ojengbede, Christopher O. Olopade, Olufunmilayo I. Olopade   +14 more
openalex   +1 more source

Plasma extrachromosomal circular DNA as a biomarker in EGFR‐targeted therapy of non‐small cell lung cancer

Molecular Oncology, EarlyView.
Detection of extrachromosomal circular DNA (eccDNA) in plasma samples from EGFR‐mutated non‐small cell lung cancer patients. Plasma was collected before and during treatment with the EGFR‐tyrosine kinase inhibitor osimertinib. Plasma eccDNA was detected in all cancer samples, and the presence of the EGFR gene on eccDNA serves as a potential biomarker ...
Simone Stensgaard, Sarmad Mehmood, Eva Boysen Fynboe Ebert, Peter Meldgaard, Anindya Dutta, Boe S. Sorensen   +5 more
wiley   +1 more source

Editorial: Application and innovation of multiomics technologies in clinical oncology

Frontiers in Oncology, 2023
Xinmin Li, Anton Budzin, Anton Budzin, Anton Budzin, Ye Wang   +4 more
doaj   +1 more source

Nutrition-Related Clinical Decision Making of Pediatric Oncology Nurses

, 2019
Amanda J. Lulloff, Judith A. Vessey, Lisa Bashore, Matt Gregas   +3 more
openalex   +2 more sources

Not at all simple: The lay language summary of oncology clinical trials results. Challenges in implementing the new EU regulation (536/2014) [PDF]

, 2016
A. Nottbohm, C. Weiss-Haljiti, Thomas M. Schindler   +2 more
openalex   +1 more source